Acute calf vein thrombosis: outcomes and implications

Prior research has established that deep vein thrombosis (DVT) occurs in the lower limbs and can lead to serious complications like pulmonary embolism. However, the specific role and clinical significance of isolated acute calf vein thrombosis (CVT) remain unclear. While proximal DVT has been extensively studied, CVT is less frequently reported and its outcomes are not well characterized. It was already known that DVT can progress from distal to proximal veins, but the rate and risk factors for this progression in CVT cases had not been fully explored. No prior work had resolved whether anticoagulant treatment influences the progression of CVT to proximal DVT. This gap motivated the need for a study focusing specifically on CVT. That uncertainty drove the decision to examine a large cohort of patients undergoing venous duplex imaging. The researchers aimed to clarify the incidence, progression patterns, and clinical implications of CVT in a real-world setting.

The aim of this study was to investigate the incidence and clinical outcomes of isolated acute calf vein thrombosis. The specific problem addressed was the lack of comprehensive data on how often CVT occurs and whether it progresses to more severe forms of DVT. The motivation for this work came from the observation that CVT is often overlooked in favor of proximal DVT, despite its potential clinical significance. The researchers sought to determine how frequently CVT progresses to proximal DVT and whether this progression is associated with adverse outcomes like pulmonary embolism or death. They also aimed to assess the impact of anticoagulant treatment on the progression of CVT. This study was designed to provide evidence-based insights into the management of CVT. The findings could help guide clinical decisions regarding follow-up and treatment for patients diagnosed with CVT. The study focused on outcomes that are directly relevant to patient care and risk stratification.

The study employed a retrospective analysis of venous duplex imaging data collected from a hospital-based vascular laboratory. Over a 19-month period, 3,096 patients underwent lower extremity venous duplex testing. Bilateral tibial and peroneal vein imaging were standard components of the examination. The researchers identified patients with acute calf vein thrombosis and compared them to those with proximal DVT. Venous duplex reports were reviewed to determine the incidence of CVT and the frequency of follow-up imaging. Patients who underwent follow-up testing were tracked for progression to proximal DVT. The study also collected data on comorbid conditions like cancer and the results of ventilation-perfusion (V/Q) lung scans. Anticoagulant use at the time of initial testing was recorded and analyzed for its association with progression to PDVT. The researchers used statistical analysis to compare outcomes between patients who received anticoagulants and those who did not.

The study found that 118 patients (3.8%) had isolated acute calf vein thrombosis. Among these, 25% had cancer, a significantly higher rate than in the general population. Of the 18 patients with CVT who underwent V/Q lung scans, 56% had high-probability results, suggesting a link between CVT and pulmonary embolism. Follow-up venous duplex testing was performed in 60% of CVT patients, and 15.5% of these cases progressed to proximal DVT. The incidence of progression was 25% in patients receiving anticoagulants versus 5.7% in those not receiving them (P = 0.046). Patients who progressed to PDVT were more likely to have cancer (35% versus 7.8%; P = 0.009) and high-probability V/Q scans (36% versus 6.7%; P = 0.017). Mortality was also higher in this group (27% versus 1.7%; P = 0.011). These findings suggest that CVT is associated with significant clinical risks and that progression to PDVT is a critical event with adverse outcomes.

The authors concluded that isolated acute calf vein thrombosis is less common than proximal DVT but still carries important clinical implications. They emphasized that CVT is associated with a higher risk of pulmonary embolism and death, particularly in patients who progress to PDVT. The study found that anticoagulant treatment at the time of diagnosis was linked to a higher rate of progression to PDVT, suggesting that treatment decisions may influence outcomes. The researchers proposed that patients with CVT should be closely monitored for progression to proximal DVT. They noted that cancer was a significant risk factor for both progression and adverse outcomes. The findings suggest that CVT should not be considered a benign condition and that follow-up imaging is essential. The authors highlighted the importance of recognizing CVT as a potential precursor to more severe forms of DVT. They recommended further research to clarify the optimal management strategies for patients with CVT.